Özcan Met

3.9k total citations
81 papers, 2.3k citations indexed

About

Özcan Met is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Özcan Met has authored 81 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Immunology, 51 papers in Oncology and 26 papers in Molecular Biology. Recurrent topics in Özcan Met's work include Immunotherapy and Immune Responses (48 papers), CAR-T cell therapy research (35 papers) and Cancer Immunotherapy and Biomarkers (28 papers). Özcan Met is often cited by papers focused on Immunotherapy and Immune Responses (48 papers), CAR-T cell therapy research (35 papers) and Cancer Immunotherapy and Biomarkers (28 papers). Özcan Met collaborates with scholars based in Denmark, Netherlands and Germany. Özcan Met's co-authors include Inge Marie Svane, Marco Donia, Mads Hald Andersen, Per thor Straten, Troels Holz Borch, Christopher A. Chamberlain, Rikke Andersen, Eva Ellebæk, Morten Hansen and Trine Zeeberg Iversen and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Özcan Met

77 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Özcan Met Denmark 29 1.5k 1.5k 591 236 163 81 2.3k
Robin Parihar United States 22 1.5k 1.0× 1.4k 0.9× 482 0.8× 197 0.8× 197 1.2× 47 2.3k
Eva Lion Belgium 29 1.9k 1.3× 1.3k 0.9× 731 1.2× 174 0.7× 215 1.3× 64 2.6k
Liza B. John Australia 16 1.2k 0.8× 1.7k 1.2× 612 1.0× 399 1.7× 389 2.4× 27 2.4k
Peisheng Hu United States 29 986 0.7× 812 0.5× 722 1.2× 255 1.1× 135 0.8× 62 2.0k
Cristina Puig-Saus United States 13 1.0k 0.7× 1.4k 0.9× 704 1.2× 238 1.0× 161 1.0× 18 2.0k
Natalia Aptsiauri Spain 31 1.9k 1.3× 1.6k 1.1× 726 1.2× 157 0.7× 81 0.5× 55 2.9k
Arantza Azpilikueta Spain 26 1.8k 1.2× 1.6k 1.1× 438 0.7× 180 0.8× 127 0.8× 47 2.4k
Fubin Li China 19 2.1k 1.4× 1.4k 0.9× 729 1.2× 83 0.4× 149 0.9× 42 3.0k
Michael Klichinsky United States 14 902 0.6× 1.3k 0.9× 586 1.0× 327 1.4× 315 1.9× 56 2.0k
Carsten Linnemann Netherlands 17 1.8k 1.2× 1.7k 1.1× 736 1.2× 316 1.3× 130 0.8× 21 2.5k

Countries citing papers authored by Özcan Met

Since Specialization
Citations

This map shows the geographic impact of Özcan Met's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Özcan Met with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Özcan Met more than expected).

Fields of papers citing papers by Özcan Met

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Özcan Met. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Özcan Met. The network helps show where Özcan Met may publish in the future.

Co-authorship network of co-authors of Özcan Met

This figure shows the co-authorship network connecting the top 25 collaborators of Özcan Met. A scholar is included among the top collaborators of Özcan Met based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Özcan Met. Özcan Met is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borch, Troels Holz, Maartje W. Rohaan, Inge Jedema, et al.. (2023). 57P Anatomical location of metastasis and composition of the final infusion product in metastatic melanoma (MM) patients treated with tumor-infiltrating lymphocytes (TIL). Immuno-Oncology Technology. 20. 100530–100530. 1 indexed citations
2.
Chamberlain, Christopher A., Eric Bennett, Anders Kverneland, et al.. (2022). Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy. Molecular Therapy — Oncolytics. 24. 417–428. 50 indexed citations
3.
Borch, Troels Holz, Katja Harbst, Rikke Andersen, et al.. (2021). Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma. Journal for ImmunoTherapy of Cancer. 9(7). e002703–e002703. 21 indexed citations
4.
Harbst, Katja, Troels Holz Borch, Marie Christine Wulff Westergaard, et al.. (2020). CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer. Scientific Reports. 10(1). 3914–3914. 50 indexed citations
5.
Levring, Trine B., Helene Myrtue Nielsen, Lise M. Lindahl, et al.. (2020). The Thioredoxin-Interacting Protein TXNIP Is a Putative Tumour Suppressor in Cutaneous T-Cell Lymphoma. Dermatology. 237(2). 283–290. 6 indexed citations
6.
Draghi, Arianna, Cathrin Ritter, Tina Seremet, et al.. (2019). MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells. Cancer Immunology Research. 7(9). 1472–1484. 40 indexed citations
7.
Levring, Trine B., Martin Kongsbak‐Wismann, Özcan Met, et al.. (2019). Tumor necrosis factor induces rapid down-regulation of TXNIP in human T cells. Scientific Reports. 9(1). 16725–16725. 20 indexed citations
8.
Ahmad, Shamaila Munir, Morten Hansen, Charlotte M. Bonefeld, et al.. (2019). Inflammation induced PD-L1-specific T cells. SHILAP Revista de lepidopterología. 3(10). 319–327. 17 indexed citations
9.
Andersen, Rikke, Marie Christine Wulff Westergaard, Julie Westerlin Kjeldsen, et al.. (2018). T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma—Implications for Adoptive Cell Therapy. Cancer Immunology Research. 6(2). 222–235. 57 indexed citations
10.
Andersen, Rikke, Marco Donia, Eva Ellebæk, et al.. (2016). Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen. Clinical Cancer Research. 22(15). 3734–3745. 234 indexed citations
11.
Andersen, Rikke, Marie Christine Wulff Westergaard, Julie Westerlin Kjeldsen, et al.. (2016). T cell responses in the microenvironment of primary renal cell carcinoma. Annals of Oncology. 27. vi365–vi365. 1 indexed citations
12.
Selmeczi, Dávid, Thomas Hansen, Özcan Met, Inge Marie Svane, & Niels B. Larsen. (2016). Large-Scale mRNA Transfection of Dendritic Cells by Electroporation in Continuous Flow Systems. Methods in molecular biology. 1428. 151–161. 1 indexed citations
13.
Lyngaa, Rikke, Natasja Wulff Pedersen, David Schrama, et al.. (2014). T-cell Responses to Oncogenic Merkel Cell Polyomavirus Proteins Distinguish Patients with Merkel Cell Carcinoma from Healthy Donors. Clinical Cancer Research. 20(7). 1768–1778. 76 indexed citations
14.
Donia, Marco, et al.. (2014). Simplified protocol for clinical-grade tumor-infiltrating lymphocyte manufacturing with use of the Wave bioreactor. Cytotherapy. 16(8). 1117–1120. 41 indexed citations
15.
Ahmad, Shamaila Munir, Özcan Met, Marco Donia, et al.. (2013). HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients. Cancer Research. 73(6). 1764–1776. 58 indexed citations
16.
Hjortø, Gertrud M., et al.. (2013). In-chip fabrication of free-form 3D constructs for directed cell migration analysis. Lab on a Chip. 13(24). 4800–4800. 47 indexed citations
17.
Cathelin, Dominique, Özcan Met, & Inge Marie Svane. (2013). Silencing of the glucocorticoid-induced leucine zipper improves the immunogenicity of clinical-grade dendritic cells. Cytotherapy. 15(6). 740–749. 14 indexed citations
18.
Ellebæk, Eva, Trine Zeeberg Iversen, Niels Junker, et al.. (2012). Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients. Journal of Translational Medicine. 10(1). 169–169. 134 indexed citations
19.
Hansen, Morten, Gertrud M. Hjortø, Marco Donia, et al.. (2012). Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy. Vaccine. 31(4). 639–646. 27 indexed citations
20.
Selmeczi, Dávid, Thomas Hansen, Özcan Met, Inge Marie Svane, & Niels B. Larsen. (2011). Efficient large volume electroporation of dendritic cells through micrometer scale manipulation of flow in a disposable polymer chip. Biomedical Microdevices. 13(2). 383–392. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robin Parihar Breakdown of academic impact, for papers by Eva Lion Breakdown of academic impact, for papers by Liza B. John Breakdown of academic impact, for papers by Peisheng Hu Breakdown of academic impact, for papers by Cristina Puig-Saus Breakdown of academic impact, for papers by Natalia Aptsiauri Breakdown of academic impact, for papers by Arantza Azpilikueta Breakdown of academic impact, for papers by Fubin Li Breakdown of academic impact, for papers by Michael Klichinsky Breakdown of academic impact, for papers by Carsten Linnemann
Rankless by CCL
2026